Summary Box: FDA concerned about expanding use of antidepressant Cymbalta to treat pain

By AP
Tuesday, August 17, 2010

Summary Box: FDA reviews Cymbalta for chronic pain

NOT JUST FOR DEPRESSION: The Food and Drug Administration is raising questions about the antidepressant Cymbalta, as Eli Lilly & Co. requests approval to market the drug for chronic pain.

BLOCKBUSTER BOTTOMLINE: Cymbalta is already a multibillion dollar drug used by nearly 15 million patients. The FDA is concerned about expanding use of the drug because it has been associated with liver damage.

PANEL OPINION: On Thursday a panel of outside advisers will vote on whether Cymbalta is safe and effective for chronic pain. The FDA is not required to follow their advice, though it often does.

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :